Clinical Oncology
Volume 22, Issue 5 , Page 391 , June 2010

Exocrine Insufficiency and Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer

  • L. Watson

      Affiliations

    • Corresponding Author InformationDepartment of Nutrition & Dietetics, University Hospital of North Staffordshire, Newcastle Road, Stoke-on-Trent ST4 6QG, UK. Tel: +44-17823-553069.

References 

  1. Keller J, Aghdassi AA, Lerch MM, Mayerle JV, Layer P. Tests of pancreatic exocrine function – clinical significance in pancreatic and non-pancreatic disorders. Best Pract Res Clin Gastroenterol. 2009;23:425–439
  2. Ihse I, Arnesjo B, Kugelberg C, Lilja P. Intestinal activities of trypsin, lipase and phospholipase after a test meal. An elevation of 474 examinations. Scan J Gastroenterol. 1977;12:663–668
  3. Matsumoto J, Traverso LW. Exocrine function following the whipple operation as assessed by stool elastase. J Gastrointest Surg. 2006;10:1225–1229
  4. Kato H, Nakao A, Kishimoto W, et al. 13C-labeled trioctanion breath test for exocrine pancreatic function test in patients after pancreatoduodenectomy. Am J Gastroenterol. 1993;88:64–69
  5. Pancreatic Section of the British Society of Gastroenterology , Pancreatic Society of Great Britain and Ireland , Royal College of Pathologists , Special Interest Group for Gastro-Intestinal Radiology . Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut. 2005;54(Suppl. V):v1–v16
  6. Bruno MJ, Haverkort EB, Tijssen GP, Tytgat GN, van Leeuwen DJ. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut. 1998;42:92–96

PII: S0936-6555(10)00085-3

doi: 10.1016/j.clon.2010.03.004

Clinical Oncology
Volume 22, Issue 5 , Page 391 , June 2010

Article Tools